FDA
Ponatinib Hydrochloride
The FDA lists this product in 2 strengths and forms.
Composition
- Active ingredients
- PONATINIB HYDROCHLORIDE EQ 15MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PONATINIB HYDROCHLORIDE EQ 15MG BASE · TabletThis page
- PONATINIB HYDROCHLORIDE EQ 45MG BASE · TabletANDA215893-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA215893.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ponatinib Hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Apotex
- Status
- Discontinued
- FDA approval
- 14 Jul 2023
- Application
- ANDA215893-001